Inspire Medical Systems Stock Performance
| INSP Stock | USD 77.68 2.51 3.34% |
The company retains a Market Volatility (i.e., Beta) of 2.49, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Inspire Medical will likely underperform. At this point, Inspire Medical Systems has a negative expected return of -0.62%. Please make sure to check out Inspire Medical's treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Inspire Medical Systems performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Inspire Medical Systems has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in November 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors. ...more
Actual Historical Performance (%)
One Day Return 1.18 | Five Day Return (0.37) | Year To Date Return (58.45) | Ten Year Return 214.65 | All Time Return 214.65 |
1 | 13 Analysts Have This To Say About Inspire Medical Systems | 08/15/2025 |
2 | Disposition of 7159 shares by Richard Buchholz of Inspire Medical at 42.15 subject to Rule 16b-3 | 08/19/2025 |
3 | Inspire Medical Systems Navigating Stock Volatility with Strategic Growth | 08/27/2025 |
4 | INVESTOR ALERT Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inspire Medical Systems, Inc. - INSP | 09/08/2025 |
5 | Expert Outlook Inspire Medical Systems Through The Eyes Of 15 Analysts | 09/22/2025 |
6 | Inspire Medical Systems Valuation in Focus Following Patent Lawsuit from Nyxoah | 09/23/2025 |
7 | Inspire Medical to effect up to 200M stock buyback program - MSN | 09/26/2025 |
8 | Inspire Medical Systems, Inc. Stock Analysis A 74.95 percent Upside Potential For Investors - DirectorsTalk Interviews | 09/29/2025 |
9 | INSPIRE MEDICAL ALERT Bragar Eagel Squire, P.C. Reminds Investors of the Investigation into Inspire Medical Systems, Inc. and Encourages Investors to Contact th... | 10/03/2025 |
10 | Inspire Medical Systems, Inc. to Report Third Quarter 2025 Financial Results on November 3, 2025 | 10/06/2025 |
11 | Valeo Financial Advisors LLC Lowers Position in Inspire Medical Systems, Inc. INSP | 10/09/2025 |
12 | Inspire Medical Systems, Inc. Publishes Inspire V Data at ISSSAAO-HNS Meetings | 10/10/2025 |
| Begin Period Cash Flow | 185.5 M | |
| Total Cashflows From Investing Activities | -113.1 M |
Inspire Medical Relative Risk vs. Return Landscape
If you would invest 12,750 in Inspire Medical Systems on July 16, 2025 and sell it today you would lose (4,982) from holding Inspire Medical Systems or give up 39.07% of portfolio value over 90 days. Inspire Medical Systems is currently does not generate positive expected returns and assumes 5.0914% risk (volatility on return distribution) over the 90 days horizon. In different words, 45% of stocks are less volatile than Inspire, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Inspire Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Inspire Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Inspire Medical Systems, and traders can use it to determine the average amount a Inspire Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1218
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | INSP |
Estimated Market Risk
| 5.09 actual daily | 45 55% of assets are more volatile |
Expected Return
| -0.62 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.12 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Inspire Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Inspire Medical by adding Inspire Medical to a well-diversified portfolio.
Inspire Medical Fundamentals Growth
Inspire Stock prices reflect investors' perceptions of the future prospects and financial health of Inspire Medical, and Inspire Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Inspire Stock performance.
| Return On Equity | 0.0807 | ||||
| Return On Asset | 0.0338 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | (0.02) % | ||||
| Current Valuation | 1.92 B | ||||
| Shares Outstanding | 29.57 M | ||||
| Price To Earning | 15.29 X | ||||
| Price To Book | 3.23 X | ||||
| Price To Sales | 2.67 X | ||||
| Revenue | 802.8 M | ||||
| Gross Profit | 727.55 M | ||||
| EBITDA | 65.03 M | ||||
| Net Income | 53.51 M | ||||
| Cash And Equivalents | 196.32 M | ||||
| Cash Per Share | 7.10 X | ||||
| Total Debt | 31.79 M | ||||
| Debt To Equity | 0.14 % | ||||
| Current Ratio | 5.62 X | ||||
| Book Value Per Share | 22.92 X | ||||
| Cash Flow From Operations | 130.25 M | ||||
| Earnings Per Share | 1.74 X | ||||
| Market Capitalization | 2.3 B | ||||
| Total Asset | 808.38 M | ||||
| Retained Earnings | (291.91 M) | ||||
| Working Capital | 542.3 M | ||||
| Current Asset | 167.55 M | ||||
| Current Liabilities | 64.84 M | ||||
About Inspire Medical Performance
Assessing Inspire Medical's fundamental ratios provides investors with valuable insights into Inspire Medical's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Inspire Medical is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 237.78 | 193.74 | |
| Return On Tangible Assets | 0.07 | 0.07 | |
| Return On Capital Employed | 0.05 | 0.05 | |
| Return On Assets | 0.07 | 0.07 | |
| Return On Equity | 0.08 | 0.08 |
Things to note about Inspire Medical Systems performance evaluation
Checking the ongoing alerts about Inspire Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Inspire Medical Systems help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Inspire Medical generated a negative expected return over the last 90 days | |
| Inspire Medical has high historical volatility and very poor performance | |
| Inspire Medical is unlikely to experience financial distress in the next 2 years | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: Susquehanna Downgrades Rambus to Hold |
- Analyzing Inspire Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Inspire Medical's stock is overvalued or undervalued compared to its peers.
- Examining Inspire Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Inspire Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Inspire Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Inspire Medical's stock. These opinions can provide insight into Inspire Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Inspire Stock Analysis
When running Inspire Medical's price analysis, check to measure Inspire Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inspire Medical is operating at the current time. Most of Inspire Medical's value examination focuses on studying past and present price action to predict the probability of Inspire Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inspire Medical's price. Additionally, you may evaluate how the addition of Inspire Medical to your portfolios can decrease your overall portfolio volatility.